Broncare Pellet
NDC Package 55714-4840-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Broncare (echinacea, lappa, rumex crisp., antimon. tart., arsenicum alb., bryonia, camphora, chelidonium maj., cinchona, drosera, eucalyptus, hepar sulph. calc., histaminum hydrochloricum, ipecac., kali bic., kali carb., kali iod., lycopodium, myrrha, nat. sulphuricum, nux vom., phos., pulsatilla, sainguinaria, spongia, stannum met., tussilago far., verbascum, influenzinum) pellets is formulated for symptoms such as excess mucus, cough, congestion and shortness of breath. This formulation utilizes a pellet delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4840.

Identification & Billing

NDC Package Code
55714-4840-1
Package Description
28 g in 1 BOTTLE, GLASS
Product Code
55714-4840
11-Digit Billing Format
55714484001

Clinical Specifications

Proprietary Name
Broncare
Non-Proprietary Name
Echinacea, Lappa, Rumex Crisp., Antimon. Tart., Arsenicum Alb., Bryonia, Camphora, Chelidonium Maj., Cinchona, Drosera, Eucalyptus, Hepar Sulph. Calc., Histaminum Hydrochloricum, Ipecac., Kali Bic., Kali Carb., Kali Iod., Lycopodium, Myrrha, Nat. Sulphuricum, Nux Vom., Phos., Pulsatilla, Sainguinaria, Spongia, Stannum Met., Tussilago Far., Verbascum, Influenzinum
Substance Name
Anemone Pulsatilla; Antimony Potassium Tartrate; Arctium Lappa Root; Arsenic Trioxide; Bryonia Alba Root; Calcium Sulfide; Camphor (natural); Chelidonium Majus; Cinchona Officinalis Bark; Drosera Anglica; Echinacea, Unspecified; Histamine Dihydrochloride; Influenza A Virus; Influenza B Virus; Ipecac; Lycopodium Clavatum Spore; Myrrh; Phosphorus; Potassium Carbonate; Potassium Dichromate; Potassium Iodide; Rumex Crispus Root; Sanguinaria Canadensis Root; Sodium Sulfate; Spongia Officinalis Skeleton, Roasted; Strychnos Nux-vomica Seed; Tin; Tussilago Farfara; Verbascum Thapsus
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Formulated for symptoms such as excess mucus, cough, congestion and shortness of breath.

Regulatory & Marketing

Labeler Name
Newton Laboratories, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-18-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55714-4840-1 identifies a specific commercial package of 28 g in 1 bottle, glass of Broncare, a human over the counter drug labeled by Newton Laboratories, Inc.. This pellet is formulated for oral use and contains anemone pulsatilla; antimony potassium tartrate; arctium lappa root; arsenic trioxide; bryonia alba root; calcium sulfide; camphor (natural); chelidonium majus; cinchona officinalis bark; drosera anglica; echinacea, unspecified; histamine dihydrochloride; influenza a virus; influenza b virus; ipecac; lycopodium clavatum spore; myrrh; phosphorus; potassium carbonate; potassium dichromate; potassium iodide; rumex crispus root; sanguinaria canadensis root; sodium sulfate; spongia officinalis skeleton, roasted; strychnos nux-vomica seed; tin; tussilago farfara; verbascum thapsus as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on May 18, 2020. The current certification is valid through December 31, 2026.

How is this Newton Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714484001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55714-4840-1
11-Digit CMS (5-4-2)
55714-4840-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.